18 Jul Satellite Biosciences
Tom Lowery, Ph.D., President and CEO
Oct. 7 | 9:30am | FLW Ballroom G
Newton, MA
(Private)
Satellite Biosciences is a liver cell therapy company with cutting-edge hepatocyte technologies aimed at addressing a broad range of severe liver diseases. We have two drug candidates with regulatory feedback and are entering the clinic in 2026. Our platform encompasses a proprietary primary hepatocyte expansion technology that allows dosing of thousands of patients from a single donor liver. Additionally, we specialize in stabilizing hepatocyte function to optimize for engraftment and durability as well as for long-term stability and shipment. Our therapies have the profile that more closely resembles a traditional drug than a typical cell or gene therapy: they are off-the-shelf, stable, worldwide shippable, ready-to-infuse, and have a very low cost-of-goods.
